Company Overview

Research, development and commercialisation of healthcare products based on strains of bacteria that produce bacteriocins, the supply of healthcare ingredients and the manufacture of part and finished goods and other food products for sale in domestic and international markets.

Directors and Management

Dr Alison Stewart

Non-Executive Director 28/09/2018

Dr Stewart is Christchurch based and was appointed to the Board in August 2018. Dr Stewart brings to the board governance and commercial research and development experience within the international biotechnology industry. Dr Stewart has held key executive leadership roles in New Zealand and US corporates and understands the drivers for successful commercialisation of research. Dr Stewart is an experienced research and innovation leader with expertise in microbe-based product development, patents, IP protection, new product pipeline and development of strategic partnerships with large international corporations. Dr Stewart is a Distinguished Emeritus Professor at Lincoln University, NZ and was elected a Companion of the NZ Order of Merit in 2011 for her contributions to biology.

Male

Mr Geoff Plunket

Non-Executive Director 04/05/2018

Mr Plunket is currently a Dunedin based Professional Director and Consultant and has been a director of Blis Technologies Limited since May 2018 and was appointed Audit Committee Chair in August 2018. Mr Plunket worked for Coopers & Lybrand (now PWC) and KPMG, in Dunedin and Birmingham, UK through the 1980's before joining Port Otago Limited in 1988, as Chief Financial Officer. Mr Plunket spent the following 29 years with the Port Otago Group, before retiring in 2017. Mr Plunket worked across the business in a of roles, culminating in appointment as CEO in 2004, a position he held until retirement. Mr Plunket brings significant experience in a successful organisation with expertise in logistics, managing international trading relationships, supply chain, human resource, health and safety and risk management.

CA Male

Mr Barry Richardson

Non-Executive Director 27/07/2018

Dr Richardson is Dunedin based and has been a director of Blis Technologies Limited since July 2018. Dr Richardson began his career as a scientist at the NZ Dairy Research Institute before joining the NZ Dairy Board in 1985 as a Business Development Manager, undertaking roles in several biotechnology and nutritional Dairy Board joint venture companies. Dr Richardson joined the Tatua Co-Operative Dairy Company Limited in 1991 as General Manager, Tatua Biologics and was later appointed General Manager, International and Strategic Development commercialising value added dairy ingredients. He was appointed CEO of Westland Milk Products when that company elected to be an independent exporter of dairy products in late 2001. From 2006 to 2016 Dr Richardson was CEO of Blis Technologies Limited, through the period when the Company transitioned from a research company into a commercial entity. His other professional roles include a Director of CertusBio and a Director of CNS Biotechnology

Male

Mr Anthony (Tony) P Offen

Non-Executive Director,Non-Executive Chairman 13/05/2009

Mr Offen is Dunedin based and has been a Director and shareholder of Blis Technologies Limited since May 2009. Mr Offen was appointed Board Chair in August 2017 and has previously served as Deputy Chair and Chair of the Audit Committee. Through his Dunedin-based investment company, Mr Offen has been a director and shareholder of private companies involved in commercial property, FMCG business sectors nationally and internationally and with investment interests requiring venture and start-up capital. He is an elected Member of the National Council for the Neurological Foundation of NZ and has served as the Council Deputy Chair and Chair of its Risk Management Committee.

B.Com (Acc), BA (Philosophy), MCANZ&A, CMID Male

Mr Antony (Tony) Balfour

Non-Executive Director 08/04/2020

Mr Balfour has governance experience following an executive career as an international marketing and brand management executive building consumer goods businesses globally. Tony has a background of international experience in driving FMCG through retail channels and e-commerce from the leadership roles he held for Nike Inc, Icebreaker, Seek.com and Monster Worldwide. Tony holds current directorships with The Warehouse, Les Mills International and Wayfare Ltd (trading as Real Journeys). He retired in 2019 as a director of Silver Fern Farms after 10 years and of Methven Limited with the sale of that company

BCom Male

Ms Veronica Aris

Non-Executive Director 25/07/2014

Ms Aris is Auckland based and was appointed to the Board in July 2014 and appointed Chair of the Remuneration Committee in April 2017. Ms Aris has over 20 years in senior marketing and sales roles that span the innovation, primary care consumables, pharmaceuticals, natural health care, consumer and safety product markets. She is currently the Head of Sales and Marketing for the Icehouse where she leads a team of eight, delivering strategy and digital transformation to more than 5,000 ambitious owner-managers and entrepreneurs. Ms Aris is also currently a board Member of both Altus and Clinical Advisory Services Aotearoa (CASA) and has previously been on Boards for the North Auckland Kindergarten Association and the Torbay Sailing Club.

BSc (Chem),CCIM, CMID Female

Mr Graem S Boyd

Non-Executive Director 25/07/2014

Mr Boyd is based in Tauranga and has been a director of Blis Technologies Limited since July 2014. He was appointed Deputy Chair in August 2018. Mr Boyd joined ICI New Zealand Limited in 1971 and for over 26 years held a of positions across the business, including management of the Pharmaceuticals Division, culminating in the role of NZ General Manager from 1990 to 1997. He was appointed CEO of Comvita in 1998 and developed the company from a small privately-owned company to a publicly-listed company centred on marketing natural health products internationally. Mr Boyd left Comvita in 2005 and formed a management consulting business specialising in company turnarounds, growth strategies and international marketing.

CMID, MSC (Chemistry) Male

Mr Tom Ronnlund

Non-Executive Director 22/07/2021

Mr Ronnlund has more than 20 years' experience working in the healthcare industry, and has held several positions in sales, marketing and general management at IQVIA and in international biopharmaceutical companies such as Bristol-Myers Squibb and Eli Lilly. Mr Ronnlund is currently the CEO of Probi AB, a Swedish listed biotechnology company. Founded in Lund in 1991, Probi today is one of the global probiotics companies. Before joining Probi AB in January 2019, Mr Ronnlund served as CEO of Navamedic ASA, a listed Norwegian pharma and medtech company.

Male

Top 20 Shareholders

Director Transactions